CytomX Therapeutics, Inc. (CTMX)
5.705
+0.04
(+0.62%)
USD |
NASDAQ |
Feb 09, 16:00
5.705
0.00 (0.00%)
After-Hours: 20:00
CytomX Therapeutics Profit Margin (Quarterly) : -238.6% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| REGENXBIO, Inc. | -208.3% |
| ACADIA Pharmaceuticals, Inc. | 25.76% |
| Alnylam Pharmaceuticals, Inc. | 20.10% |
| Savara, Inc. | -- |
| BioMarin Pharmaceutical, Inc. | -3.91% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 61.32% |
| Return on Assets | 20.20% |
| Return on Invested Capital | 52.07% |
| Gross Profit Margin (Quarterly) | 97.75% |
| Operating Margin (Quarterly) | -266.1% |
| Return on Net Operating Assets | 212.8% |